Published in Neuron on January 14, 2010
Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science (2010) 5.42
Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron (2011) 4.74
Genetic animal models of Parkinson's disease. Neuron (2010) 3.86
The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci (2013) 2.78
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J (2012) 2.36
Recent advances in the genetics of Parkinson's disease. Annu Rev Genomics Hum Genet (2011) 2.29
Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J (2010) 2.12
Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem (2011) 1.96
Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs. Mol Biol Cell (2010) 1.89
Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway. Proc Natl Acad Sci U S A (2011) 1.85
αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc Natl Acad Sci U S A (2010) 1.83
A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J Neurosci (2010) 1.80
α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies. J Neurosci (2011) 1.79
Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins. J Biol Chem (2010) 1.69
Dopamine release in the basal ganglia. Neuroscience (2011) 1.67
The function of α-synuclein. Neuron (2013) 1.63
α-Synuclein in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.62
Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. J Neurosci (2011) 1.56
SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch Neurol (2010) 1.54
v-SNARE composition distinguishes synaptic vesicle pools. Neuron (2011) 1.54
Parkinson's disease: insights from pathways. Hum Mol Genet (2010) 1.52
α-Synuclein and dopamine at the crossroads of Parkinson's disease. Trends Neurosci (2010) 1.49
α-Synuclein promotes dilation of the exocytotic fusion pore. Nat Neurosci (2017) 1.42
α-Synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding. J Cell Biol (2011) 1.41
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons. Proc Natl Acad Sci U S A (2012) 1.40
The N-terminus of the intrinsically disordered protein α-synuclein triggers membrane binding and helix folding. Biophys J (2010) 1.39
The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol (2017) 1.37
Parkinson's disease and α-synuclein expression. Mov Disord (2011) 1.34
Integrating pathways of Parkinson's disease in a molecular interaction map. Mol Neurobiol (2013) 1.34
Soluble α-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci (2012) 1.34
Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2. Elife (2013) 1.31
α-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. J Neurosci (2012) 1.27
Monomeric synucleins generate membrane curvature. J Biol Chem (2012) 1.27
Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking. Proc Natl Acad Sci U S A (2013) 1.26
Alpha-synuclein: from secretion to dysfunction and death. Cell Death Dis (2012) 1.25
Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo. Proc Natl Acad Sci U S A (2013) 1.24
Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation. Nat Chem Biol (2015) 1.22
Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J Biol Chem (2011) 1.22
Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep (2010) 1.17
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci U S A (2013) 1.17
The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures. Hum Mutat (2013) 1.17
Animal models of Parkinson's disease: limits and relevance to neuroprotection studies. Mov Disord (2012) 1.17
α-synuclein multimers cluster synaptic vesicles and attenuate recycling. Curr Biol (2014) 1.14
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PLoS One (2010) 1.13
α-Synuclein induces both positive mean curvature and negative Gaussian curvature in membranes. J Am Chem Soc (2012) 1.13
Neuronal vulnerability, pathogenesis, and Parkinson's disease. Mov Disord (2012) 1.11
Synucleins regulate the kinetics of synaptic vesicle endocytosis. J Neurosci (2014) 1.10
Mapping the subcellular distribution of α-synuclein in neurons using genetically encoded probes for correlated light and electron microscopy: implications for Parkinson's disease pathogenesis. J Neurosci (2013) 1.09
Single molecule characterization of α-synuclein in aggregation-prone states. Biophys J (2010) 1.09
Biophysics of α-synuclein membrane interactions. Biochim Biophys Acta (2011) 1.08
ESCRT-mediated uptake and degradation of brain-targeted α-synuclein single chain antibody attenuates neuronal degeneration in vivo. Mol Ther (2014) 1.08
Remodeling of lipid vesicles into cylindrical micelles by α-synuclein in an extended α-helical conformation. J Biol Chem (2012) 1.07
Chaperoning the SNAREs: a role in preventing neurodegeneration? Nat Cell Biol (2011) 1.07
LRRK2 function on actin and microtubule dynamics in Parkinson disease. Commun Integr Biol (2010) 1.04
Optogenetic reporters: Fluorescent protein-based genetically encoded indicators of signaling and metabolism in the brain. Prog Brain Res (2012) 1.03
Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease. PLoS One (2013) 1.03
Genetic therapy for the nervous system. Hum Mol Genet (2011) 1.03
Deletion of alpha-synuclein decreases impulsivity in mice. Genes Brain Behav (2011) 1.03
In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility. PLoS One (2010) 1.02
Presenilins in synaptic function and disease. Trends Mol Med (2011) 1.02
Role of α-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus. J Neurosci (2012) 1.01
α-Synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers. Biochemistry (2013) 1.01
α-Synuclein: the long distance runner. Brain Pathol (2013) 0.99
Membrane trafficking in neuronal maintenance and degeneration. Cell Mol Life Sci (2012) 0.99
Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system. PLoS One (2013) 0.99
Alpha-synuclein function and dysfunction on cellular membranes. Exp Neurobiol (2014) 0.99
The role of mitochondrially derived ATP in synaptic vesicle recycling. J Biol Chem (2015) 0.98
α-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. J Biol Chem (2012) 0.98
α-Synuclein oligomers impair neuronal microtubule-kinesin interplay. J Biol Chem (2013) 0.98
The Synaptic Function of α-Synuclein. J Parkinsons Dis (2015) 0.98
Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake. Int J Biol Sci (2011) 0.98
Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome. J Clin Invest (2012) 0.97
N-terminal acetylation stabilizes N-terminal helicity in lipid- and micelle-bound α-synuclein and increases its affinity for physiological membranes. J Biol Chem (2013) 0.97
Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein. PLoS One (2011) 0.96
Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease. J Cell Physiol (2015) 0.96
Aggregation of α-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis. J Mol Neurosci (2010) 0.96
α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment. J Alzheimers Dis (2013) 0.96
Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease. J Neurosci (2014) 0.96
α-Synuclein and mitochondria: partners in crime? Neurotherapeutics (2013) 0.95
Concurrent imaging of synaptic vesicle recycling and calcium dynamics. Front Mol Neurosci (2011) 0.95
α-Synuclein oligomers with broken helical conformation form lipoprotein nanoparticles. J Biol Chem (2013) 0.95
Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease. Hum Mol Genet (2014) 0.95
Specificity and kinetics of alpha-synuclein binding to model membranes determined with fluorescent excited state intramolecular proton transfer (ESIPT) probe. J Biol Chem (2011) 0.94
Mutant protein A30P α-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics. J Biol Chem (2012) 0.94
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model. Eur J Neurosci (2012) 0.94
Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways. Brain Behav Immun (2012) 0.94
Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice. Hum Mol Genet (2014) 0.94
Impaired intracellular trafficking defines early Parkinson's disease. Trends Neurosci (2015) 0.94
An extracellular mechanism that can explain the neurotoxic effects of α-synuclein aggregates in the brain. Front Physiol (2012) 0.93
Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease. PLoS One (2014) 0.92
α-Synuclein and neuronal cell death. Mol Neurobiol (2012) 0.92
Dynamin-related protein 1 is required for normal mitochondrial bioenergetic and synaptic function in CA1 hippocampal neurons. Cell Death Dis (2015) 0.91
A system for performing high throughput assays of synaptic function. PLoS One (2011) 0.91
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J Neurochem (2016) 0.91
Traumatic brain injury dysregulates microRNAs to modulate cell signaling in rat hippocampus. PLoS One (2014) 0.91
α-Synuclein and mitochondrial dysfunction in Parkinson's disease. Mol Neurobiol (2013) 0.91
The impact of genetic research on our understanding of Parkinson's disease. Prog Brain Res (2010) 0.90
α-Synuclein-induced membrane remodeling is driven by binding affinity, partition depth, and interleaflet order asymmetry. J Am Chem Soc (2014) 0.90
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30
Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2002) 22.40
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol (2007) 17.69
Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature (1998) 15.09
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol (2004) 9.62
Membrane fusion: grappling with SNARE and SM proteins. Science (2009) 8.98
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A (1998) 8.41
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science (2006) 7.72
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet (2004) 7.69
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron (2000) 6.92
alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol (2002) 6.64
Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell (2005) 6.31
Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron (1996) 6.26
Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem (1998) 5.81
A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis. Science (2007) 4.86
The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron (1995) 4.78
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron (2002) 4.77
Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science (2003) 4.45
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci (1988) 4.36
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA (2006) 4.26
Essential functions of synapsins I and II in synaptic vesicle regulation. Nature (1995) 4.25
Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron (2009) 4.18
Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci (2002) 4.01
Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling. Neuron (2006) 3.85
The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci U S A (2007) 3.39
Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci (2006) 3.37
Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron (1995) 3.37
Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A (2002) 3.33
A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. J Mol Biol (2003) 2.97
Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci (2005) 2.91
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science (2003) 2.89
Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron (2002) 2.65
Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci (2004) 2.65
Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci U S A (2004) 2.62
Rapid reuse of readily releasable pool vesicles at hippocampal synapses. Neuron (2000) 2.59
Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection. Exp Neurol (2005) 2.46
The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. Neuron (2004) 2.43
Dopamine neurons make glutamatergic synapses in vitro. J Neurosci (1998) 2.33
Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci (1999) 2.32
Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J Biol Chem (2000) 2.27
Short-term synaptic plasticity is altered in mice lacking synapsin I. Cell (1993) 2.23
Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem (2002) 2.07
beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron (2001) 2.05
Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology (2004) 2.05
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov Disord (2006) 1.93
Development of vesicle pools during maturation of hippocampal synapses. J Neurosci (2002) 1.87
Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J Neurosci (2003) 1.80
Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. J Neurosci (2005) 1.75
Role of alpha-synuclein in presynaptic dopamine recruitment. J Neurosci (2004) 1.74
Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein. Biochemistry (2004) 1.71
The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. Biochemistry (2007) 1.63
Neural activity controls the synaptic accumulation of alpha-synuclein. J Neurosci (2005) 1.62
A combinatorial code for the interaction of alpha-synuclein with membranes. J Biol Chem (2005) 1.60
Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res (2000) 1.53
Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine. J Neurochem (2004) 1.52
Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. J Mol Biol (2002) 1.52
Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem (2000) 1.49
Alpha-synuclein and the Lewy body disorders. Curr Opin Neurol (2001) 1.48
Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol Biol Cell (2008) 1.48
Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis (2001) 1.48
Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. Mol Cell Proteomics (2008) 1.46
Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein. Eur J Neurosci (2008) 1.38
Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. Biochemistry (2003) 1.36
Synaptic vesicle recycling in synapsin I knock-out mice. J Cell Biol (1996) 1.31
Structural determinants of PLD2 inhibition by alpha-synuclein. J Mol Biol (2004) 1.29
The cerebellum-specific Munc13 isoform Munc13-3 regulates cerebellar synaptic transmission and motor learning in mice. J Neurosci (2001) 1.22
Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines. Neuron (2005) 1.21
alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases. J Biol Chem (2000) 1.13
Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers. Neurology (2001) 1.09
Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J Neurochem (1997) 0.92
Evidence that alpha-synuclein functions as a negative regulator of Ca(++)-dependent alpha-granule release from human platelets. Blood (2002) 0.87
Ge/Si nanowire heterostructures as high-performance field-effect transistors. Nature (2006) 8.50
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet (2009) 8.44
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
AMPA receptor trafficking at excitatory synapses. Neuron (2003) 7.11
Nanoscale memristor device as synapse in neuromorphic systems. Nano Lett (2010) 6.28
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet (2003) 5.92
Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc Natl Acad Sci U S A (2002) 4.77
Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet (2011) 4.50
Identification of PSD-95 palmitoylating enzymes. Neuron (2004) 4.37
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Improved synthesis of graphene oxide. ACS Nano (2010) 4.32
Endocannabinoid signaling in the brain. Science (2002) 4.28
Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins. Neuron (2006) 4.21
Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron (2009) 4.18
Synaptic strength regulated by palmitate cycling on PSD-95. Cell (2002) 4.15
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Stargazin modulates AMPA receptor gating and trafficking by distinct domains. Nature (2005) 3.88
Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling. Neuron (2006) 3.85
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of Cdc42. Cell (2003) 3.66
Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat Rev Neurosci (2008) 3.52
Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science (2006) 3.52
Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J Neurosci (2010) 3.47
VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci (2004) 3.45
Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci (2006) 3.37
Soy food intake and breast cancer survival. JAMA (2009) 3.16
Single-cell optogenetic excitation drives homeostatic synaptic depression. Neuron (2010) 3.15
Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science (2004) 3.15
Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins. J Cell Biol (2003) 3.14
Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron (2009) 3.11
Observation of conducting filament growth in nanoscale resistive memories. Nat Commun (2012) 3.02
Glycopeptide and lipoglycopeptide antibiotics. Chem Rev (2005) 3.01
Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3. Neuron (2008) 2.96
Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci (2011) 2.90
Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci (2006) 2.85
The expanding social network of ionotropic glutamate receptors: TARPs and other transmembrane auxiliary subunits. Neuron (2011) 2.82
AMPARs and synaptic plasticity: the last 25 years. Neuron (2013) 2.80
The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci U S A (2002) 2.77
Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron (2010) 2.75
Rapid bidirectional switching of synaptic NMDA receptors. Neuron (2007) 2.72
Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet (2012) 2.70
Nitrogen fixation island and rhizosphere competence traits in the genome of root-associated Pseudomonas stutzeri A1501. Proc Natl Acad Sci U S A (2008) 2.70
Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci (2004) 2.65
LTP requires a reserve pool of glutamate receptors independent of subunit type. Nature (2012) 2.59
Focused ultrasound to expel calculi from the kidney. J Urol (2011) 2.55
Postsynaptic density-95 mimics and occludes hippocampal long-term potentiation and enhances long-term depression. J Neurosci (2003) 2.53
Novel breathing motion model for radiotherapy. Int J Radiat Oncol Biol Phys (2005) 2.51
Arc/Arg3.1: linking gene expression to synaptic plasticity and memory. Neuron (2006) 2.50
Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors. Nature (2009) 2.45
Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc Natl Acad Sci U S A (2005) 2.45
Metabolic control of vesicular glutamate transport and release. Neuron (2010) 2.44
Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet (2007) 2.44
The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol (2011) 2.42
Photoinactivation of native AMPA receptors reveals their real-time trafficking. Neuron (2005) 2.40
Energy doubling of 42 GeV electrons in a metre-scale plasma wakefield accelerator. Nature (2007) 2.36
Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins. Trends Cell Biol (2007) 2.35
Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo. J Neurosci (2012) 2.35
In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther (2008) 2.34
Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J Neurosci (2002) 2.31
Conservation of glutamate receptor 2-containing AMPA receptors during long-term potentiation. J Neurosci (2007) 2.30
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
The MCART radiation physics core: the quest for radiation dosimetry standardization. Health Phys (2014) 2.23
Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat Med (2010) 2.15
Bidirectional synaptic plasticity regulated by phosphorylation of stargazin-like TARPs. Neuron (2005) 2.13
Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials (2009) 2.13
Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression. Neuropharmacology (2006) 2.10
TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating. Neuron (2007) 2.07
Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A (2010) 2.07
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res (2009) 2.07
A functional hybrid memristor crossbar-array/CMOS system for data storage and neuromorphic applications. Nano Lett (2011) 2.06
TARP gamma-8 controls hippocampal AMPA receptor number, distribution and synaptic plasticity. Nat Neurosci (2005) 2.04
Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet (2004) 2.02
A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J Am Chem Soc (2010) 2.02
Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron (2012) 2.00
Mitochondrial dynamics in neurodegeneration. Trends Cell Biol (2012) 1.99
Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet (2010) 1.98
Dynamic interaction of stargazin-like TARPs with cycling AMPA receptors at synapses. Science (2004) 1.97
Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem (2011) 1.96
Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo. J Neurosci (2012) 1.95
A multimodal location and routing model for hazardous materials transportation. J Hazard Mater (2012) 1.93
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One (2011) 1.93
Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet (2012) 1.91
Thyronamines inhibit plasma membrane and vesicular monoamine transport. ACS Chem Biol (2007) 1.91
Novel ultrasound method to reposition kidney stones. Urol Res (2010) 1.90
Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev (2010) 1.87
Cellular localization of three vesicular glutamate transporter mRNAs and proteins in rat spinal cord and dorsal root ganglia. Synapse (2003) 1.87
The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature (2013) 1.86
Tracking lung tissue motion and expansion/compression with inverse consistent image registration and spirometry. Med Phys (2007) 1.86
A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1. Cell (2013) 1.84
Short-term memory to long-term memory transition in a nanoscale memristor. ACS Nano (2011) 1.81
Time trends and characteristics of childhood cancer among children age 0-14 in Shanghai. Pediatr Blood Cancer (2009) 1.78